Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

2.2K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
2.2K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

465
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
465
Analgesia and Pain Management01:25

Analgesia and Pain Management

856
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
856
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

409
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
409
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

3.0K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.0K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

2.8K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing antidepressant use in geriatric depression: expert consensus from French societies of geriatrics, old age psychiatry, and clinical pharmacy (SFGG, SF3PA, and SFPC).

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same author

GHSR agonism increases blood glucose but delays food intake in GHSR hyperresponsive rats.

Journal of neuroendocrinology·2026
Same author

Traumatic-like fear memory recall causes persistent morphine conditioned place preference in drug withdrawn male mice.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same author

Stereodivergent Hydrohalogenation of SCF<sub>3</sub> Alkynes and Cross- Coupling Reactions.

Organic letters·2024
Same author

Photocatalyzed Cascade Hydrogen Atom Transfers for Assembly of Multi-Substituted α-SCF<sub>3</sub> and α-SCF<sub>2</sub>H Cyclopentanones.

Angewandte Chemie (International ed. in English)·2024
Same author

Oxycodone, an opioid like the others?

Frontiers in psychiatry·2023

Related Experiment Video

Updated: Sep 30, 2025

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

2.8K

Biased Opioid Ligands: Revolution or Evolution?

Florence Noble1, Nicolas Marie1

  • 1Université de Paris, CNRS ERL 3649 Pharmacologie et thérapies des addictions, Inserm UMR-S 1124 T3S Environmental Toxicity, Therapeutic Targets Cellular Signaling and Biomarkers, Paris, France.

Frontiers in Pain Research (Lausanne, Switzerland)
|March 17, 2022
PubMed
Summary

New biased opioid ligands offer hope for pain relief without dangerous side effects like overdose. This review explores their potential to address the ongoing opioid crisis.

Keywords:
PZM21TRV130analgesiabiased ligandsopioidsside effects

More Related Videos

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
10:13

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding

Published on: June 9, 2017

16.6K
Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
09:09

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography

Published on: September 20, 2016

11.6K

Related Experiment Videos

Last Updated: Sep 30, 2025

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

2.8K
Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
10:13

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding

Published on: June 9, 2017

16.6K
Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
09:09

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography

Published on: September 20, 2016

11.6K

Area of Science:

  • Pharmacology
  • Medicinal Chemistry
  • Neuroscience

Background:

  • Opioids are potent analgesics but cause significant side effects, including tolerance, dependence, and fatal respiratory depression.
  • The North American opioid crisis necessitates the development of safer pain management alternatives.
  • Biased opioid ligands are emerging as a promising strategy to mitigate adverse effects.

Purpose of the Study:

  • To review recent advancements in biased opioid ligand discovery.
  • To evaluate the efficacy of these novel ligands in reducing opioid-related side effects.
  • To assess their potential to address the limitations of current opioid analgesics.

Main Methods:

  • Literature review of peer-reviewed studies on biased opioid ligands.
  • Analysis of preclinical and clinical data on ligand efficacy and safety profiles.
  • Comparative assessment of biased ligands against traditional opioids.

Main Results:

  • Several novel biased opioid ligands have been identified with potentially improved safety profiles.
  • Early data suggests reduced tolerance and respiratory depression in preclinical models.
  • Further research is needed to confirm efficacy and safety in human clinical trials.

Conclusions:

  • Biased opioid ligands represent a promising therapeutic avenue for safer analgesia.
  • These compounds could play a crucial role in managing chronic pain and combating the opioid crisis.
  • Continued investigation is essential to translate these findings into clinical practice.